Company Quick10K Filing
Biologix Hair
10-Q 2021-03-31 Filed 2021-05-07
10-K 2020-12-31 Filed 2021-03-16
10-Q 2020-09-30 Filed 2020-11-09
10-Q 2020-06-30 Filed 2020-08-06
10-Q 2020-03-31 Filed 2020-05-11
10-K 2019-12-31 Filed 2020-03-16
10-Q 2019-09-30 Filed 2019-11-06
10-Q 2019-06-30 Filed 2019-08-08
10-Q 2019-03-31 Filed 2019-05-09
10-K 2018-12-31 Filed 2019-03-18
10-Q 2018-09-30 Filed 2018-11-09
10-Q 2018-06-30 Filed 2018-08-01
10-Q 2018-03-31 Filed 2018-05-01
10-K 2017-12-31 Filed 2018-02-22
10-Q 2017-09-30 Filed 2017-11-01
10-Q 2017-06-30 Filed 2017-08-02
10-Q 2017-03-31 Filed 2017-05-02
10-K 2016-12-31 Filed 2017-02-22
10-Q 2016-09-30 Filed 2016-11-02
10-Q 2016-06-30 Filed 2016-08-02
10-Q 2016-03-31 Filed 2016-05-03
10-K 2015-12-31 Filed 2016-02-29
10-Q 2015-09-30 Filed 2015-11-09
10-Q 2015-06-30 Filed 2015-07-30
10-Q 2015-03-31 Filed 2015-05-05
10-K 2014-12-31 Filed 2015-03-02
10-Q 2014-09-30 Filed 2014-11-06
10-Q 2014-06-30 Filed 2014-08-08
10-Q 2014-03-31 Filed 2014-05-01
10-K 2013-12-31 Filed 2014-02-28
10-Q 2013-09-30 Filed 2013-11-04
10-Q 2013-06-30 Filed 2013-08-02
10-Q 2013-03-31 Filed 2013-05-03
10-K 2012-12-31 Filed 2013-03-01
10-Q 2012-09-30 Filed 2012-11-02
10-Q 2012-06-30 Filed 2012-08-02
10-Q 2012-03-31 Filed 2012-05-04
10-K 2011-12-31 Filed 2012-03-02
10-Q 2011-09-30 Filed 2011-11-03
10-Q 2011-06-30 Filed 2011-08-04
10-Q 2011-03-31 Filed 2011-05-05
10-K 2010-12-31 Filed 2011-03-04
10-Q 2010-09-30 Filed 2010-11-03
10-Q 2010-06-30 Filed 2010-08-04
10-Q 2010-03-31 Filed 2010-05-05
10-K 2009-12-31 Filed 2010-03-04
8-K 2020-11-09
8-K 2020-10-30
8-K 2020-08-24
8-K 2020-08-05
8-K 2020-05-21
8-K 2020-05-11
8-K 2020-03-26
8-K 2020-03-16
8-K 2020-01-28
8-K 2019-11-06
8-K 2019-10-08
8-K 2019-08-08
8-K 2019-06-28
8-K 2019-05-10
8-K 2019-05-02
8-K 2019-03-19
8-K 2019-02-22
8-K 2018-11-09
8-K 2018-11-01
8-K 2018-08-16
8-K 2018-08-02
8-K 2018-06-04
8-K 2018-05-10
8-K 2018-05-02
8-K 2018-05-01
8-K 2018-02-22
8-K 2018-02-19

Biologix Hair Financials

TG Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
1347 Capital Corp (TFSC)
CNB Financial (CCNE) 450 5.1 1% 3,541 3,244 0 0 39 78 398
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
Timberline Resources (TLR)
Almost Never Films (HLWD)
1st United Bancorp (FUBC)
Manchester United (MANU) 0% 1,497 0 0 0 0 -308
SQL Technologies (SQFL) 18% 1.5 0% 7 30 9 2 0 2 3
2-Track Global (TTG)
GB Sciences (GBLX) 23 -23% -1.8 -56% 30 16 4 -1 -17 -13 23
Nemaura Medical (NMRD) 158 -32.0 -182% 3 3 0 0 -5 -5 156
Monroe Bank and Trust (MBTF) 232 -6.6 1% 1,327 1,191 0 0 10 16 -107
Solis Tek (SLTK) 44 51% -25.8 -163% 1 7 2 1 -2 -2 44
Cumulus Media (CMLS) -94.7 -0% 0 0 0 -11 1,004
Cyclo Therapeutics, Inc. (CYTHW)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash9410969715344533944435345134111118107101969296971111021031091053636623734364045
Accounts Receivable97951069091110128
Inventory363561647066757978777171707074737366656667736676848287858593941009385
PP&E692670746758743744749756758780799812827801791764772750755776792795798847861881771781772778793798795797
Assets601603779792754738783789799793793809806807789770758664623636642656651768808812756756754691707749730731
Accounts Payable6564747880688289928883918498949885778474828881949696108107121128113111107104
Long-Term Debt0125122988012811914213813914915015013714914714710414314314395193187177152141123911021107368
Liabilities165162382386357331411410431417390392383392417421402383351344336338340449449438412393387362353377342333
Stockholders' Equity436441397406397407372379368377403416424415372349356282273291306318311319359374344363367329355373388398
Income Statement ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue201204204220235222233242266243231235237240239234221224217207209208205221247247246259264
Cost of Revenue195197205177177209
Gross Profit38343440283748
R&D333433333333333444455555544455455
SG&A151820192116191819181818171718172215182020171920222122222121222423
Tax3-0447574535545-3513-03101234-6355-744-0
Net Income613-03771041798512131017-6731224448-181815-3426201417
Cash Flow ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating21231413223391224321072014127144151416144183235155721115718
Cash Investing-2-186-9-3-11-53-10-24-19-24-10-8-9-11-7-6-9-9-7-11-12-12-100-14-11-1-1-8-11-13-11-2
Cash Financing-1124-4-27-2024-1019-73-7-0-1-43-9-5-34-3-17-4-095-9-14-29-15-20-364-42-9